Tecsys (TSE:TCS – Get Free Report) had its target price hoisted by investment analysts at ATB Cormark Capital Markets from C$41.00 to C$46.00 in a research report issued on Monday, BayStreet reports. The brokerage currently has an “outperform” rating on the stock. ATB Cormark Capital Markets’ price target would suggest a potential upside of 27.78% from the stock’s previous close.
TCS has been the topic of a number of other research reports. Canaccord Genuity Group upgraded Tecsys to a “strong-buy” rating in a research note on Thursday, August 6th. TD set a C$39.00 target price on shares of Tecsys and gave the company a “buy” rating in a research note on Wednesday, July 8th. National Bank Financial upped their price target on shares of Tecsys from C$40.00 to C$41.00 and gave the stock an “outperform” rating in a report on Monday, September 14th. Finally, TD Securities raised shares of Tecsys to a “strong-buy” rating in a research note on Thursday, July 9th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$38.90.
View Our Latest Report on Tecsys
Tecsys Trading Up 0.2%
Tecsys (TSE:TCS – Get Free Report) last released its earnings results on Thursday, September 10th. The company reported C$0.21 EPS for the quarter. Tecsys had a return on equity of 9.76% and a net margin of 3.24%.The firm had revenue of C$50.05 million for the quarter. Sell-side analysts predict that Tecsys will post 0.4600739 earnings per share for the current year.
Insider Activity
In other news, Director David Brereton sold 2,400 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of C$30.00, for a total transaction of C$72,000.00. Following the transaction, the director owned 706,572 shares of the company’s stock, valued at approximately C$21,197,160. This represents a 0.34% decrease in their position. Over the last 90 days, insiders sold 6,600 shares of company stock worth $205,322. 17.05% of the stock is currently owned by corporate insiders.
About Tecsys
Tecsys is trusted by mission-critical organizations in healthcare and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven software with deep domain expertise, Tecsys delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. Tecsys is publicly traded on the Toronto Stock Exchange (TCS). For more information, visit www.tecsys.com.
Recommended Stories
- Five stocks we like better than Tecsys
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for Tecsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tecsys and related companies with MarketBeat.com's FREE daily email newsletter.
